Medine.co.uk

Out of date information, search another

Ezetimibe 10 Mg Tablets

Out of date information, search another
Document: document 1 change

SAME SIZE ARTWORK

LEAFLET SIZE: 120 mm x 450 mm

Package leaflet: Information for the user Ezetimibe 10 mg Tablets

Ezetimibe


Read all of this leaflet carefully

before you start taking this

medicine because it contains

important information for you.

-    Keep this leaflet. You may need to read it again.

-    If you have any further questions, ask your doctor or pharmacist.

-    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

-    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1.    What Ezetimibe is and what it is used for

2.    What you need to know before you take Ezetimibe

3.    How to take Ezetimibe

4.    Possible side effects

5.    How to store Ezetimibe

6.    Contents of the pack and other information


1. What Ezetimibe is and what it is used for


Ezetimibe is a medicine to lower increased levels of cholesterol. Ezetimibe lowers levels of total cholesterol, "bad" cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood. In addition, Ezetimibe raises levels of "good" cholesterol (HDL cholesterol).

Ezetimibe, the active ingredient of Ezetimibe tablets, works by reducing the cholesterol absorbed in your digestive tract.

Ezetimibe adds to the cholesterollowering effect of statins, a group of medicines that reduce the cholesterol your body makes by itself.

Cholesterol is one of several fatty substances found in the bloodstream. Your total cholesterol is made up mainly of LDL and HDL cholesterol.

LDL cholesterol is often called “bad” cholesterol because it can build up in the walls of your arteries forming plaque. Eventually this plaque build-up can lead to a narrowing of the arteries. This narrowing can slow or block blood flow to vital organs such as the heart and brain. This blocking of blood flow can result in a heart attack or stroke.

HDL cholesterol is often called “good” cholesterol because it helps keep the bad cholesterol from building up in the arteries and protects against heart disease. Triglycerides are another form of fat in your blood that may increase your risk for heart disease.

Ezetimibe is used for patients who cannot control their cholesterol levels by cholesterol lowering diet alone. You should stay on your cholesterol lowering diet while taking this medicine.

Ezetimibe is used in addition to your cholesterol lowering diet if you have:

•    a raised cholesterol level in your blood (primary hypercholesterolaemia). It may be used on its own or together with a statin when your cholesterol level is not well controlled with a statin alone

•    a hereditary illness that increases the cholesterol level in your blood (known as (homozygous familial hypercholesterolaemia). You will also be prescribed a statin and may also receive other treatments

•    a hereditary illness that increases the levels of plant sterols in your blood (known as homozygous sitosterolaemia or phytosterolaemia).

Ezetimibe does not help you lose weight.


Do not take Ezetimibe together with a statin:

•    if you currently have liver problems

•    if you are pregnant or breast feeding.

Warnings and precautions

•    Tell your doctor about all your medical conditions including allergies.

•    Your doctor should do a blood test before you start taking Ezetimibe with a statin. This is to check how well your liver is working.

•    Your doctor may also want you to have blood tests to check how well your liver is working after you start taking Ezetimibe with a statin.

If you have moderate or severe liver problems, Ezetimibe is not recommended.

The combined use of Ezetimibe and fibrates (medicines for lowering cholesterol) should be avoided since its safety and effectiveness has not been established.

Children

Ezetimibe is not recommended for children under age of 10.

Other medicines and Ezetimibe

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

In particular, tell your doctor if you are taking medicine(s) with any of the following active ingredients:

   ciclosporin (often used in organ transplant patients)

•    medicines with an active ingredient to prevent blood clots, such as warfarin, phenprocoumon, acenocoumarol or fluindione (anticoagulants)

   colestipol, colestyramine, colesevelam (also used to lower cholesterol), because it affects the way ezetimibe works see also section 3 “How to take Ezetimibe”

   fibrates (also used to lower cholesterol)

Pregnancy and breast-feeding Do not take Ezetimibe with a statin if you are pregnant, are trying to get pregnant or think you may be pregnant. If you get pregnant while taking Ezetimibe with a statin, stop taking both medicines immediately and tell your doctor.

If you are taking Ezetimibe without a statin, ask your doctor for advice if you are pregnant, are trying to get pregnant or think you may be pregnant..

Do not take Ezetimibe if you are breast-feeding, because it is not known if the medicines are passed into breast milk.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Some people may get dizzy after taking Ezetimibe. If you feel dizzy, talk to your doctor or pharmacist before driving or operating machinery.

Ezetimibe contains lactose

Ezetimibe tablets contain a sugar called lactose. If your doctor has told you that you have intolerance to some sugars, contact your doctor before taking this medicine.


3. How to take Ezetimibe


2. What you need to know before you take Ezetimibe


If you use Ezetimibe together with a statin, please read the package leaflet of that particular medicine. Do not take Ezetimibe:

• if you are allergic to ezetimibe or to any of the other ingredients of Ezetimibe (listed in section 6),


Always take Ezetimibe exactly as your doctor has told you. Continue taking your other cholesterollowering medicines unless your doctor tells you to stop. You should check with your doctor or pharmacist if you are not sure.

•    Before starting Ezetimibe, you should be on a diet to lower your cholesterol.

•    You should keep on this cholesterol lowering diet whilst taking Ezetimibe.

Adults, adolescents and children

(10 to 17 years of age): The dose is one Ezetimibe 10 mg Tablet by mouth once a day.

Take Ezetimibe at any time of the day. You can take it with or without food.

If your doctor has prescribed Ezetimibe along with a statin, both medicines can be taken at the same time. In this case, please read the dosage instructions in the package leaflet of that particular medicine.


If your doctor has prescribed Ezetimibe along with any medicine containing colestyramine, colestipol or colesevelam, you should take Ezetimibe at least 2 hours before or 4 hours after taking the other medicine.

If you take more Ezetimibe than you should

Please contact your doctor or pharmacist.

If you forget to take Ezetimibe

Do not take an extra dose, just take your normal amount of Ezetimibe at the usual time the next day.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


IRL - Dublin 2;

Tel: +353 1 6764971;

Fax: +353 1 6762517.

Website: www.hpra.ie;

E-mail: medsafety@hpra.ie.

United Kingdom Yellow Card Scheme Website:

www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Ezetimibe


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness. This is because on rare occasions, muscle problems, including muscle breakdown resulting in kidney damage, can be serious and may become a potentially life-threatening condition.

Allergic reactions, including swelling of the face, lips, tongue, and/or throat that may cause difficulty in breathing or swallowing (which requires treatment right away) have been reported in general use.

When Ezetimibe was used alone, the following side effects were reported :

Common side effects (may affect up to 1 in 10 people):

•    abdominal pain •flatulence

•    diarrhoea •feeling tired Uncommon side effects (may affect up to 1 in 100 people):

•    elevations in some laboratory blood tests of liver (transaminases) or muscle (CK) function

•    cough • neck pain

•    indigestion • decreased appetite

•    heartburn • pain

•    nausea • muscle spasms

•    joint pain • hot flush

•    chest pain • high blood pressure

Additionally, when Ezetimibe was used with a statin, the following side effects were reported:

Common side effects (may affect up to 1 in 10 people):

•    elevations in some laboratory blood tests of liver function (transaminases)

•    headache • tenderness

•    muscle pain • weakness

Uncommon side effects (may affect up to 1 in 100 people):

•    tingling sensation

•    dry mouth • muscle weakness

•    itching • pain in arms and

•    rash    legs

•    hives • unusual tiredness

or weakness

•    back pain • swelling,

especially in the hands and feet

When Ezetimibe was used with fenofibrate, the following side effect was reported:

Common side effect (may affect up to 1 in 10 people):

•    abdominal pain.

The following side effects have also been reported in general use:

dizziness; muscle aches; liver problems; allergic reactions including rash and hives; raised red rash, sometimes with target shaped lesions (erythema multiforme); muscle pain, tenderness or weakness; muscle breakdown; gallstones or inflammation of the gallbladder (which may cause abdominal pain, nausea, vomiting); inflammation of the pancreas often with severe abdominal pain; constipation; reduction in blood cell counts, which may cause bruising/bleeding (thrombocytopaenia); tingling sensation; depression; unusual tiredness or weakness; shortness of breath.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via:

Ireland

HPRA Pharmacovigilance,

Earlsfort Terrace,


•    Keep this medicine out of the sight and reach of children.

•    Do not use this medicine after the expiry date stated on the labelling after “EXP.” The expiry date refers to the last day of that month.

•    This medicinal product does not require any special storage conditions.

•    For bottle packs only: use within 200 days after first opening of the bottle

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Ezetimibe contains

The active substance is ezetimibe. Each tablet contains 10 mg ezetimibe.

The other ingredients are: lactose monohydrate; sodium lauryl sulphate, croscarmellose sodium, povidone K-30 and magnesium stearate.

What Ezetimibe looks like and contents of the pack

Ezetimibe tablets are white to off-white, capsule shaped, approximately 8.0 x 4.0 x 2.6 mm in size, flat, beveled edged uncoated tablets engraved with 'G' on one side and “44” on the other side.

Ezetimibe 10 mg tablets are available in PVC/Aclar- aluminium foil blisters of 14, 28, 30, 50, 98 and 100 tablets and HDPE bottles of 100 tablets.

*Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Glenmark Pharmaceuticals Europe Limited

Laxmi House, 2B Draycott Avenue, Kenton, Middlesex HA3 0BU United Kingdom

Manufacturer

Glenmark Pharmaceuticals Europe Limited

Building 2, Croxley Green Business Park, Croxley Green, Hertfordshire WD18 8YA, United Kingdom

Glenmark Pharmaceuticals s.r.o. Fibichova 143, 566 17 Vysoke Myto Czech Republic

This medicinal product is authorised in the Member States of the EEA under the following names:

Denmark:    Ezetimibe

Glenmark 10 mg tabletter Germany:    Ezetimibe

Glenmark 10 mg Tabletten The Netherlands:Ezetimibe Glenmark 10 mg tabletten Sweden:    Ezetimibe

Glenmark 10 mg tabletter Czech Republic: Ezetimibe Glenmark 10 mg tablety

Slovakia:    Ezetimibe

Glenmark 10 mg tablety

Ireland,

United Kingdom: Ezetimibe

10 mg Tablets

This leaflet was last revised in 05/2015.


DATE: 20-05-2015

VERSION: 06 (UK)